Treatment of Coagulase-Negative Staphylococcus Line Infection

Initial Diagnostic Confirmation

• The Infectious Diseases Society of America recommends confirming true infection versus contamination by obtaining blood cultures from both the catheter and a peripheral vein, as coagulase-negative staphylococci are the most common blood culture contaminant but also the most common cause of CRBSI 1, 2
• A differential time to positivity (DTTP) of ≥2 hours between catheter and peripheral cultures is highly sensitive and specific for catheter-related bacteremia, according to the European Society for Medical Oncology 3
• Multiple positive blood cultures from different sites strongly indicate true CRBSI rather than contamination, as stated by the Infectious Diseases Society of America 1, 2

Catheter Management Decision

• The European Society for Medical Oncology recommends removing the catheter if severe sepsis or systemic inflammatory response syndrome is present, or if suppurative thrombophlebitis or endocarditis is suspected 4
• The Infectious Diseases Society of America suggests attempting catheter salvage if the patient is clinically stable without systemic toxicity, and no tunnel or pocket infection is present 3, 4

Antibiotic Selection

• The European Society for Medical Oncology recommends starting with vancomycin administered through the infected line when possible to cover Gram-positive organisms including methicillin-resistant strains 3
• The Infectious Diseases Society of America suggests adjusting antibiotics based on antimicrobial susceptibility testing, with a treatment duration of 5-7 days for uncomplicated infection if the catheter is removed 1, 2

Treatment Duration

• The Infectious Diseases Society of America recommends 5-7 days of systemic antibiotics for uncomplicated infection if the catheter is removed 1, 2
• The European Society for Medical Oncology suggests 10-14 days of systemic antibiotics combined with antibiotic lock therapy if the catheter is retained 1, 4, 2

Special Considerations

• The Infectious Diseases Society of America recommends managing Staphylococcus lugdunensis similarly to S. aureus CRBSI due to its propensity for endocarditis and metastatic infections, requiring catheter removal and 4-6 weeks of antimicrobial therapy 1, 2
• The European Society for Medical Oncology states that in neutropenic patients, catheter retention was successful in 46% of neonatal cases and 93% of adult cases when treated appropriately, though catheter retention is a significant risk factor for recurrence 3